Detailed review on Bevacizumab and its target therapies
Crossref DOI link: https://doi.org/10.53022/oarjbp.2023.9.1.0042
Published Online: 2023-10-30
Update policy: https://doi.org/10.53022/oarj.ourcrossmarkpolicy
Ankit Kumar,
S P Srinivas Nayak,
Ronit Kumar Arvind,
